Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.75
Bid: 32.50
Ask: 33.00
Change: -0.25 (-0.76%)
Spread: 0.50 (1.538%)
Open: 32.50
High: 32.75
Low: 32.50
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Enters into Largest Royalty Agreement To Date

7 Dec 2021 07:00

RNS Number : 7491U
Duke Royalty Limited
07 December 2021
 

7 December 2021

 

Duke Royalty Limited

 

("Duke Royalty", "Duke" or the "Company")

 

Enters into Largest Royalty Agreement To Date

 

Duke Royalty (AIM:DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce that it has entered into a US$21.0 million (approximately £15.9 million) royalty financing agreement (the "Financing") with Atlas Signs Holdings, Inc. ("Atlas"). This partnership represents Duke's largest investment to date and expands upon the Company's North American presence.

 

Atlas is a US-based, turnkey national brand implementation company that delivers signage, sign maintenance, lighting, installation, and project management services to the world's leading companies.

 

Highlights:

 

· Initial cash yield of 12.5% per annum via monthly payments, which commence immediately

· 30-year secured financing, with distributions to be adjusted annually to reflect Atlas' consolidated revenue growth, on typical Duke terms

· Founded in 1992, Atlas is a family owned company with a long history of successful operations, providing a complete range of signage-related products and services

· Atlas has a diverse and long-standing customer base including national and Fortune 500 companies

· Duke's financing will support the refinancing of Atlas' current debt, general working capital and growth initiatives

 

Neil Johnson, CEO of Duke Royalty, said:

 

"This partnership is the largest investment in our history and further diversifies our revenue base. We believe Atlas is a good example of a company that is seeking long-term capital to replace conventional private credit. We believe the pandemic has opened the opportunity for Duke to appeal to a broader number and larger companies. As an owner-operator business with proven profitability and growth, a history of successful operations with major national brands and a strong customer service reputation, Atlas represents the ideal royalty partner for Duke and we are delighted to support it with our long-term financing."

 

Jim Adinolfe, CEO and Founder of Atlas, said:

 

"The long-term nature and flexibility of Duke's investment solution is a great fit for Atlas, as it removes the need for periodic refinancings and provides us with a secure platform for continued growth. We are excited about our long-term partnership with Duke which allows the management team to focus on getting back to business and executing on our business plan."

 

About Atlas Signs Holdings, Inc.

 

Established in 1992 in South Florida, United States as a local installer, Atlas is now a top 10 national signage provider. With international coverage and 12 offices throughout the country, Atlas employs over 200 people. The Company has operated as a family-owned business since its inception. Today, Atlas has three manufacturing facilities located across the Southern US and can design, produce and install any type of signage need that its customers may request.

 

Atlas is a provider of brand implementation products and services for Fortune 500 companies across multiple industries. Its wide range of sign and branding offerings includes custom signage, architectural elements, digital signage, custom graphics and digital prints. Atlas program management services include design and engineering, in-house permitting, fabrication, self-performing installation, custom reporting, high-rise capabilities along with post-installation service and maintenance. Managing and executing on large-scale rebranding programs and conversions are among its operating strengths.

 

About the Financing

 

Duke has provided Atlas with an investment of US$21.0 million to be used primarily for the refinancing of existing debt and for general working capital purposes.

 

The terms of the Financing are broadly in line with Duke's typical investment criteria. The Financing is provided through a secured loan and Duke will be entitled to monthly distributions (the "Distribution") beginning in December 2021.

 

In line with Duke's other investments, and reflective of the participating nature of Duke's business model, the Distribution will be adjusted annually based on the percentage change in Atlas' total gross revenues for the 12 months to 31 December 2022, compared to the prior financial (calendar) year. The first adjustment will occur from 1 January 2023. The annual adjustment in the Distribution will be subject to an agreed collar, in line with Duke's typical terms.

 

The Financing is for a period of 30 years, with the Distribution payable to Duke throughout the duration of this term, unless Atlas utilises an early buyback option which will trigger an early redemption payment to Duke.

 

Miami-based Vaupen Financial Advisors, LLC served as the financial advisors for Atlas Signs Holdings on this financing transaction.

 

Duke Royalty Portfolio

 

A full list of Duke's current Royalty Partners are now included for reference on the Partners page of our website: www.dukeroyalty.com/partners

 

This announcement contains inside information.

 

***ENDS***

 

For further information, please visit www.dukeroyalty.com or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

 

+44 (0) 1481 730 613

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

+44 (0) 207 397 8900

 

 

 

Canaccord Genuity

(Joint Broker)

 

Adam James / Georgina McCooke

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell / Richard Bicknell / Megan Kovach

 +44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long-term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTBCBDDDDGDGBL
Date   Source Headline
30th Aug 20223:07 pmRNSHolding(s) in Company
5th Aug 20227:00 amRNSNotice of Results and Presentations
4th Aug 20227:00 amRNSTrading Update
21st Jun 20227:00 amRNSInterim Dividend and Dividend Declaration
1st Jun 20224:25 pmRNSHolding(s) in Company
27th May 20229:08 amRNSDirector / PCA Dealings
26th May 20223:23 pmRNSResult of General Meeting and Issue of Equity
11th May 20227:05 amRNSRaises £20m through Placing and PrimaryBid Offer
10th May 20225:08 pmRNSPrimaryBid Offer
10th May 20224:44 pmRNSPlacing to raise a minimum of £15 million
28th Apr 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
20th Apr 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
11th Apr 20227:00 amRNSTrading Update
18th Mar 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
17th Mar 20227:00 amRNSIncreased Interim Dividend & Dividend Declaration
2nd Mar 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
25th Feb 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
17th Feb 20227:00 amRNSFurther re: Directorate Change
14th Feb 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
2nd Feb 20227:00 amRNSDirectorate Changes
1st Feb 202210:02 amRNSReplacement - Trading Update
1st Feb 20227:00 amRNSTrading Update
20th Jan 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
23rd Dec 20212:30 pmRNSHolding(s) in Company
23rd Dec 20217:01 amRNSTrading Update
23rd Dec 20217:00 amRNSFollow-on investment into existing Royalty Partner
22nd Dec 20213:52 pmRNSFollow-on investment into existing Royalty Partner
16th Dec 20217:00 amRNSNew Royalty Agreement
14th Dec 20217:00 amRNSIncreased Interim Dividend & Dividend Declaration
7th Dec 20217:00 amRNSEnters into Largest Royalty Agreement To Date
3rd Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSCompletion of £4.2 million Follow-On Investment
25th Nov 20217:00 amRNSNotice of Interim Results
29th Oct 20214:03 pmRNSLong Term Incentive Plan Awards
27th Oct 20217:01 amRNSFollow-On Investment into Existing Royalty Partner
27th Oct 20217:00 amRNSHolding(s) in Company
22nd Oct 20214:36 pmRNSResult of Annual General Meeting
16th Sep 20217:01 amRNSInterim Dividend and Dividend Declaration
16th Sep 20217:00 amRNSFinal Results
7th Sep 20217:00 amRNS£2.2m Follow-On Investment into Royalty Partner
2nd Sep 20217:00 amRNSHolding(s) in Company
17th Aug 20217:00 amRNSInvestor Presentation
11th Aug 20217:00 amRNSSuccessful Exit of Investment in Royalty Partner
10th Aug 20217:00 amRNSNotice of Results and Analyst Presentation
2nd Aug 20217:00 amRNSNew Royalty Agreement
26th Jul 20217:00 amRNSTrading Update
22nd Jul 20217:00 amRNSNew Royalty Agreement
1st Jul 20217:00 amRNSNew Royalty Agreement with Fairmed Healthcare AG
17th Jun 20217:00 amRNSInterim Dividend and Dividend Declaration
10th May 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.